Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.43 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 4/20 | 0.42 |
| ▸ | CES1 | P23141 | 4/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4149053 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL4139404 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL4163491 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL8431297 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL2482724 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL11343070 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL1742678 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL2481657 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL4155109 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL6940598 | 0.97 | CA12 (0.52) | CA12CA1CA9CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118026839-A | Purification method and application of high-purity succinic acid | 安徽丰原发酵技术工程研究有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-116203096-A | All-solid-state sodium ion selective electrode, preparation method thereof and application thereof in bioelectrolyte detection | 广州钰芯传感科技有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-115253872-A | Control system for controlling rotating speed of high-speed stirrer through feedback of volatile organic compound recovery parameters | 浙江省建筑材料科学研究所有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114380683-A | Method for extracting lactic acid from fermentation liquor containing calcium lactate | 安徽丰原发酵技术工程研究有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-114276235-A | Method for extracting citric acid from fermentation liquor containing citric acid | 安徽丰原发酵技术工程研究有限公司 | 2022-04-05 | — | — | CN | claimed |
| EP-3294735-B1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMA (US) | 2021-10-27 | — | — | EP | claimed |
| US-20200207765-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED | 2020-07-02 | — | — | US | claimed |
| EP-3068776-B1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMA (US) | 2019-05-29 | — | — | EP | claimed |
| US-10273233-B2 | Inhibitors of influenza viruses replication | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-04-30 | — | — | US | claimed |
| US-20180282330-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED | 2018-10-04 | — | — | US | claimed |
| US-20160251354-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED | 2016-09-01 | — | — | US | claimed |
| WO-2015073481-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-05-21 | — | — | WO | claimed |
| WO-2015073476-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-05-21 | — | — | WO | claimed |
| US-6787149-B1 | Topical application of opioid analgesic drugs such as morphine | EL KHOURY AND STEIN LTD. | 2004-09-07 | — | — | US | claimed |
| EP-1082006-A1 | CRYOPRESERVATION OF HUMAN RED BLOOD CELLS | LIFECELL CORPORATION (US) | 2001-03-14 | — | — | EP | claimed |
| US-6143278-A | TOPICAL ADMINISTRATION OF OPIOID ANALGESIC AGENT IN ADMIXTURE WITH SKIN OR MUCOSAL SPECIFIC PENETRATION ENHANCER TO PRODUCE LOCALIZED ANALGESIC EFFECT IN SKIN OR MUCOSAL TISSUE WITHOUT TRANSDERMAL MIGRATION OF OPIOD AGENT | ELKHOURY GEORGE F (US) | 2000-11-07 | — | — | US | claimed |
| WO-1999060849-A1 | CRYOPRESERVATION OF HUMAN RED BLOOD CELLS | LIFECELL CORPORATION (US) | 1999-12-02 | — | — | WO | claimed |
| EP-0153400-A1 | BENZAZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS | SCHERING CORPORATION (US) | 1985-09-04 | — | — | EP | claimed |
| EP-0135767-A1 | Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions | SCHERING CORPORATION (US) | 1985-04-03 | — | — | EP | claimed |
| WO-1985000808-A1 | BENZAZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS | SCHERING CORP. (US) | 1985-02-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180282330-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | ZC3HAV1, ZC3HAV1L, POLR2H | CA12 803/4885CA1 655/4885CA9 98/4885 |
| US-20160251354-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | ZC3HAV1, ZC3HAV1L, POLR2H | CA12 803/4885CA1 655/4885CA9 98/4885 |
| US-10273233-B2 | Inhibitors of influenza viruses replication | ZC3HAV1, ZC3HAV1L, RCC1 | CA12 2703/4885CA1 1841/4885CA9 1050/4885 |
| US-20200207765-A1 | METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION | ZC3HAV1, ZC3HAV1L, POLR2H | CA12 803/4885CA1 655/4885CA9 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.